About the journal
Epigenomics is a journal published by Future Medicine in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Future Medicine
- ISSN
- 1750-1911 · 1750-192X
- Country
- United Kingdom
- Access
- Not open access / not declared
- Official website
- http://www.futuremedicine.com/loi/epi
Index listings
- MEDLINE · 2009-01-01
- PUBMED · 2009-10-01
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1964
Last recorded publication year
2026
h-index
96
i10-index
1014
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 70%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101519720
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- MicroRNA in disease regulation
Show all subjects (50)
- Cancer-related gene regulation
- Cancer-related gene regulation
- Birth, Development, and Health
- Birth, Development, and Health
- Genomics and Chromatin Dynamics
- Genomics and Chromatin Dynamics
- Histone Deacetylase Inhibitors Research
- Histone Deacetylase Inhibitors Research
- Circular RNAs in diseases
- Circular RNAs in diseases
- Genetics and Neurodevelopmental Disorders
- Genetics and Neurodevelopmental Disorders
- Genetic Syndromes and Imprinting
- Genetic Syndromes and Imprinting
- Health, Environment, Cognitive Aging
- Health, Environment, Cognitive Aging
- RNA Research and Splicing
- RNA Research and Splicing
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Diet and metabolism studies
- Diet and metabolism studies
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Genetic Associations and Epidemiology
- Genetic Associations and Epidemiology
- Nutrition, Genetics, and Disease
- Nutrition, Genetics, and Disease
- Pregnancy and preeclampsia studies
- Pregnancy and preeclampsia studies
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Extracellular vesicles in disease
- Pluripotent Stem Cells Research
- Extracellular vesicles in disease
- Pluripotent Stem Cells Research
- Neonatal Respiratory Health Research
- Neonatal Respiratory Health Research
- Prenatal Screening and Diagnostics
- Prenatal Screening and Diagnostics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ